tirzepatide lifespan The Moody Longevity Trial: Can a Medication for Weight Loss Help You Age Better? A New Research Study at The University of Texas Medical Branch (UTMB) for Adults Ages 55–70 (Zepbound) Personalized GLP-1 Injection

Direct NAD+ IV Tolerability A small 2026 commercial-infusion study reported short-term tolerability data and variable exploratory metabolic outcomes, with more research needed beyond 30 days

OR Have a BMI of at least 30 with CVD or chronic kidney disease, and/or at least two weight-related complications or risk factors for CVD Have previously tried to lose weight through dietary changes People who have type 1 diabetes or who have tried a GLP-1 within the past 3 months are not eligible

however, some doctors may prescribe them off-label for the weight loss benefits

The main reasons to request a formulation without B12 would be a documented B12 allergy (extremely rare) or a preference for managing B12 supplementation separately through oral supplements

The treatment group self-administer weekly injections of 2.4 mg of semaglutide

Ferdinandi ES, Brazeau P, High K, Procter B, Fennell S, Dubreuil P